Correlation between osteoporosis and cardiovascular disease

Clinical Cases in Mineral and Bone Metabolism

Volumn 11, Issue 2, 2014, Pages 117-119

  Sprini, Delia ^a   Rini, Giovam Battista ^a   Di Stefano, Laura ^a   Cianferotti, Luisella ^b   Napoli, Nicola ^c  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Osteoporosis; Vascular calcification

Indexed keywords

ALCOHOL; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; CALCIUM; FREE RADICAL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; OSTEOPONTIN; OSTEOPROTEGERIN; PHOSPHATE; RALOXIFENE;

AGE; ALCOHOL CONSUMPTION; ATHEROSCLEROSIS; BLOOD PRESSURE; BLOOD VESSEL CALCIFICATION; BONE DEVELOPMENT; BONE LEVEL; BONE MASS; BONE MINERALIZATION; CALCIUM ABSORPTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CELL TRANSFORMATION; GENE; GENETIC POLYMORPHISM; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INFLAMMATION; INTERLEUKIN 6 GENE; LIPID METABOLISM; MENOPAUSE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; SHORT SURVEY; SMOKING; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR TISSUE;

EID: 84940275547     PISSN: 17248914     EISSN: 19713266     Source Type: Journal    
DOI: 10.11138/ccmbm/2014.11.2.117     Document Type: Short Survey

References (28)

1. Anagnostis P, Karagiannis A, Kakafika AI, Tziomalos K, Athyros VG, Mikhailidis DP. Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? Osteoporos Int. 2009 Feb;20(2):197-207.
2. McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR. Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine. 2004 Feb;23(1):1-10.
3. Brandi ML, Becherini L, Gennari L, Racchi M, Bianchetti A, Nacmias B, Sorbi S, Mecocci P, Senin U, Govoni S. Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. Biochem Biophys Res Commun. 1999 Nov 19;265(2):335-8.
4. Divers J, Register TC, Langefeld CD, Wagenknecht LE, Bowden DW, Carr JJ, Hightower RC, Xu J, Hruska KA, Freedman BI. Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes. J Bone Miner Res. 2011 Jul;26(7):1554-60. doi: 10.1002/jbmr.389. PubMed PMID: 21437982.
5. Freedman BI, Bowden DW, Ziegler JT, Langefeld CD, Lehtinen AB, Rudock ME, Lenchik L, Hruska KA, Register TC, Carr JJ. Bone morphogenetic protein 7 (BMP7) gene polymorphisms are associated with inverse relationships between vascular calcification and BMD: the Diabetes Heart Study. J Bone Miner Res. 2009 Oct;24(10):1719-27. doi: 10.1359/jbmr.090501. PubMed PMID: 19453255; PubMed Central PMCID: PMC2743282.
6. Doherty TM, Asotra K, Fitzpatrick LA, Qiao JH, Wilkin DJ, Detrano RC, Dunstan CR, Shah PK, Rajavashisth TB. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11201-6.
7. Rubin MR, Silverberg SJ. Vascular calcification and osteoporosis-the nature of the nexus. J Clin Endocrinol Metab. 2004 Sep;89(9):4243-5.
8. Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab. 2004 Sep;89(9):4246-53.
9. Wakasugi M, Wakao R, Tawata M, Gan N, Koizumi K, Onaya T. Bone mineral density measured by dual energy x-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. Bone. 1993;14(1):29-33.
10. Osako MK, Nakagami H, Koibuchi N, Shimizu H, Nakagami F, Koriyama H, Shimamura M, Miyake T, Rakugi H, Morishita R. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification. Circ Res. 2010 Aug 20;107(4):466-75.
11. Sivas F, Alemdaroǧlu E, Elverici E, Kuluǧ T, Ozoran K. Serum lipid profile: its relationship with osteoporotic vertebrae fractures and bone mineral density in Turkish postmenopausal women. Rheumatol Int. 2009 Jun;29(8):885-90.
12. Hamerman D. Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. QJM. 2005 Jul;98(7):467-84.
13. Kostenuik PJ. Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr Opin Pharmacol. 2005 Dec;5(6):618-25.
14. Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res. 2005 Nov;20(11):1912-20.
15. Price PA, June HH, Buckley JR, Williamson MK. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol. 2001 Oct;21(10):1610-6.
16. Helas S, Goettsch C, Schoppet M, Zeitz U, Hempel U, Morawietz H, Kostenuik PJ, Erben RG, Hofbauer LC. Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol. 2009 Aug;175(2):473-8. doi: 10.2353/ajpath.2009.080957. Epub 2009 Jul 9. Erratum in: Am J Pathol. 2009 Nov;175(5):2249.
17. Stojanovic OI, Lazovic M, Lazovic M, Vuceljic M. Association between atherosclerosis and osteoporosis, the role of vitamin D. Arch Med Sci. 2011 Apr;7(2):179-88.
18. Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest. 2006 May;116(5):1186-94.
19. Napoli N, Vattikuti S, Yarramaneni J, Giri TK, Nekkalapu S, Qualls C, Armamento-Villareal RC. Increased 2-hydroxylation of estrogen is associated with lower body fat and increased lean body mass in postmenopausal women. Maturitas. 2012 May;72(1):66-71.
20. Kado DM, Browner WS, Blackwell T, Gore R, Cummings SR. Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res. 2000 Oct;15(10):1974-80.
21. Hjortnaes J, Butcher J, Figueiredo JL, Riccio M, Kohler RH, Kozloff KM, Weissleder R, Aikawa E. Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur Heart J. 2010 Aug;31(16):1975-84.
22. Riancho JA, Salas E, Zarrabeitia MT, Olmos JM, Amado JA, Fernández-Luna JL, González-Macías J. Expression and functional role of nitric oxide synthase in osteoblast-like cells. J Bone Miner Res. 1995 Mar;10(3):439-46.
23. Khosla S. Is nitroglycerin a novel and inexpensive treatment for osteoporosis? JAMA. 2011 Feb 23;305(8):826-7.
24. Jamal SA, Hamilton CJ, Eastell R, Cummings SR. Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial. JAMA. 2011 Feb 23;305(8):800-7.
25. Jeong IK, Cho SW, Kim SW, Choi HJ, Park KS, Kim SY, Lee HK, Cho SH, Oh BH, Shin CS. Lipid profiles and bone mineral density in pre- and postmenopausal women in Korea. Calcif Tissue Int. 2010 Dec;87(6):507-12.
26. Vogt MT, Cauley JA, Kuller LH, Nevitt MC. Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J Bone Miner Res. 1997 Feb;12(2):283-9.
27. Price PA, Faus SA, Williamson MK. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol. 2001 May;21(5):817-24.
28. Adami S, Braga V, Zamboni M, Gatti D, Rossini M, Bakri J, Battaglia E. Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int. 2004 Feb;74(2):136-42.